BNP Paribas Asset Management’s Guardant Health GH Stock Holding History

BNP Paribas Asset Management’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$623K	Buy	4,166 +2,074	+99%	+$226K	﹤0.01%	1273
2026 Q1	$193K	Buy	2,092 +506	+32%	+$50.8K	﹤0.01%	1365
2025 Q4	$162K	Buy	1,586 +459	+41%	+$41.1K	﹤0.01%	1374
2025 Q3	$70K	Hold	1,127	–	–	﹤0.01%	950
2025 Q2	$59K	Buy	+1,127	New	+$50.3K	﹤0.01%	1090
2022 Q3	–	Sell	-186,860	Closed	-$7.54M	–	934
2022 Q2	$7.54M	Sell	186,860 -8,181	-4%	-$405K	0.03%	455
2022 Q1	$12.9M	Sell	195,041 -7,807	-4%	-$534K	0.04%	371
2021 Q4	$20.3M	Buy	202,848 +5,766	+3%	+$596K	0.07%	317
2021 Q3	$24.6M	Buy	197,082 +2,373	+1%	+$282K	0.09%	254
2021 Q2	$24.2M	Buy	194,709 +67,927	+54%	+$9.14M	0.09%	271
2021 Q1	$19.4M	Buy	+126,782	New	+$19.2M	0.08%	296

Other funds holding GH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

BNP Paribas Asset Management's GH Position: Q2 2026 in Review

BNP Paribas Asset Management increased its Guardant Health (GH) stake by 99% in Q2 2026, buying an estimated $226K and bringing the position to 4,166 shares worth $623K. The position accounts for ﹤0.01% of the portfolio, ranked #1273.

BNP Paribas Asset Management first reported a position in GH in Q1 2021 and has held it in 11 quarters since. The position peaked at $24.6M in Q3 2021. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

BNP Paribas Asset Management held 4,166 shares of Guardant Health worth $623K as of Q2 2026.
BNP Paribas Asset Management bought 2,074 Guardant Health shares in Q2 2026, an estimated $226K.
Guardant Health made up ﹤0.01% of BNP Paribas Asset Management's portfolio in Q2 2026, its #1273 holding.
BNP Paribas Asset Management first reported a position in Guardant Health in Q1 2021 and has held it in 11 quarters since.
BNP Paribas Asset Management's Guardant Health position peaked at $24.6M in Q3 2021.
597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on BNP Paribas Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.